Nurofen Junior S Okusom Naranče (Ibuprofen)

Ibuprofen, the active ingredient in Nurofen Junior S Okusom Naranče, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral liquid formulation for oral use. It treats mild to moderate pain, reduces fever, and alleviates inflammation in children. GNH USA supplies Nurofen Junior S Okusom Naranče as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to provide symptomatic relief in several common pediatric conditions.

Pain relief: reduces mild to moderate pain such as headache, toothache, or sore throat. Fever reduction: lowers elevated body temperature associated with infections. Inflammation control: eases swelling and discomfort from minor injuries or inflammatory conditions.

Adverse reactions may occur with ibuprofen use. Most are mild and self‑limiting, but serious events are possible.

Common Side Effects: - Stomach upset or dyspepsia - Nausea or vomiting - Diarrhoea - Mild skin rash - Headache - Dizziness

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reactions (anaphylaxis, angio‑edema) - Liver enzyme elevation or hepatitis - Acute kidney injury - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as neutropenia

Before using ibuprofen, consider the following safety measures.

Age restriction: not recommended for infants under 3 months without medical advice. Medical conditions: avoid in children with known peptic ulcer disease, severe liver or kidney impairment. Concurrent NSAIDs: do not combine with other NSAIDs or aspirin to reduce risk of bleeding. Alcohol use: limit alcohol intake as it may increase gastrointestinal toxicity. Pregnancy and breastfeeding: consult a healthcare professional before use. Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin) – increased bleeding risk - Other NSAIDs – additive gastrointestinal toxicity - Corticosteroids – heightened ulcer risk - ACE inhibitors or ARBs – possible renal function decline - Lithium – increased lithium levels

Moderate Interactions (Monitor Closely): - Diuretics – may reduce renal clearance of ibuprofen - Antihypertensives – possible reduction in blood pressure control - Methotrexate – decreased clearance, risk of toxicity - SSRIs – modest increase in bleeding tendency - Oral hypoglycemics – potential alteration of glucose control